Page last updated: 2024-11-04

carpipramine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Carpipramine is a tricyclic antidepressant (TCA) that was first synthesized in the 1960s. It has been studied for its effects on mood, anxiety, and pain. Carpipramine acts as a serotonin-norepinephrine reuptake inhibitor (SNRI), meaning it blocks the reabsorption of serotonin and norepinephrine in the brain. These neurotransmitters are involved in regulating mood, sleep, appetite, and other important functions. Studies have shown that carpipramine can be effective in treating major depressive disorder, anxiety disorders, and chronic pain conditions. However, carpipramine has several side effects, including dry mouth, constipation, blurred vision, and drowsiness. It is also known to interact with other medications. Due to its potential for serious side effects and the availability of newer, more effective antidepressant medications, carpipramine is not as widely used as it once was.'

carpipramine: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2580
CHEMBL ID2110775
CHEBI ID135729
SCHEMBL ID34949
MeSH IDM0049776

Synonyms (33)

Synonym
carbadipimidine
brn 0502521
bay b 4343 b
carpipramine
5h-dibenz(b,f)azepine, 10,11-dihydro-5-(3-(4-piperidino-4-carbamoylpiperidino)propyl)-
carpipraminum [inn-latin]
5-(3-(4-piperidino-4-carbamoylpiperidino)propyl)-10,11-dihydro-5(h)-dibenz(b,f)azepine
carpipramina [inn-spanish]
einecs 227-700-0
carpipramine [inn]
carpipramine (inn)
5942-95-0
D07623
CHEBI:135729
L000953
1-[3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl]-4-piperidin-1-ylpiperidine-4-carboxamide
cas_5942-95-0
bdbm81794
nsc_2580
unii-8afk6f91eq
8afk6f91eq ,
5-22-13-00540 (beilstein handbook reference)
carpipramina
carpipraminum
carpipramine [mi]
carpipramine [who-dd]
1'-(3-(10,11-dihydro-5h-dibenz(b,f)azepin-5-yl)propyl)-(1,4'-bipiperidine)-4'-carboxamide
SCHEMBL34949
CHEMBL2110775
NWPJLRSCSQHPJV-UHFFFAOYSA-N
DTXSID40208149
Q2940145
NCGC00522040-01

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dibenzooxazepineAn organic heterotricyclic compound consisting of two benzene rings fused to a seven-membered ring containing one oxygen and one nitrogen atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency22.38720.009610.525035.4813AID1479145
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
virion membraneSpike glycoproteinSevere acute respiratory syndrome-related coronavirus
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (89.47)18.7374
1990's1 (5.26)18.2507
2000's1 (5.26)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.27 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.15 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.35%)5.53%
Reviews0 (0.00%)6.00%
Case Studies7 (30.43%)4.05%
Observational0 (0.00%)0.25%
Other15 (65.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]